Stock Day Media
Innovent Biologics, Inc. | Fifty 1 Labs, Inc.
Jun 20, 2024
· 0m
<div>Innovent Biologics, Inc. (HKEX: 01801), a world-class biopharmaceutical company announced that clinical data of IBI363 (first-in-class PD-1/IL-2 α-bias bispecific antibody fusion protein) in advanced solid tumors are presented at the 2024 ESMO Virtual Plenary.<br> <br> Fifty 1 Labs, Inc. (OTCPK: CAFI), a holding company that operates in the sports supplement, fitness equipment, and health and wellness industries is pleased to provide an update to its shareholders regarding recent strategic initiatives and significant developments within the company. Over the past several …
Acest episod nu a fost încă transcris
Folosește STT.ai pentru a transcrie acest episod cu AI. Obțineți textul corect cu detectarea speaker, timelor orare și export în mai multe formate.
Detecție speaker
Ora temporală la nivel de cuvânt
Exportul ca SRT, TXT, JSON